Paragon 28 Future Growth

Future criteria checks 1/6

Paragon 28 is forecast to grow earnings and revenue by 27% and 14% per annum respectively while EPS is expected to grow by 29.8% per annum.

Key information

27.0%

Earnings growth rate

29.8%

EPS growth rate

Medical Equipment earnings growth14.2%
Revenue growth rate14.0%
Future return on equityn/a
Analyst coverage

Good

Last updated15 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:7GQ - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026334-30N/AN/A6
12/31/2025292-40N/AN/A7
12/31/2024254-54N/AN/A7
9/30/2024245-56-59-40N/A
6/30/2024235-55-74-52N/A
3/31/2024225-54-87-61N/A
12/31/2023216-48-92-64N/A
9/30/2023207-74-91-61N/A
6/30/2023201-73-88-59N/A
3/31/2023192-69-81-54N/A
12/31/2022181-67-92-49N/A
9/30/2022173-33-84-38N/A
6/30/2022162-29-75-31N/A
3/31/2022156-22-58-17N/A
12/31/2021147-14-25-3N/A
9/30/2021140-5-104N/A
6/30/20211344-94N/A
3/31/20211214-74N/A
12/31/20201113-101N/A
12/31/20191063-612N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 7GQ is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 7GQ is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 7GQ is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 7GQ's revenue (14% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: 7GQ's revenue (14% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 7GQ's Return on Equity is forecast to be high in 3 years time


Discover growth companies